Literature DB >> 8175947

Design and use of signature primers to detect carry-over of amplified material.

L Z Abbott1, T Spicer, V Bryz-Gornia, S Kwok, J Sninsky, B Poiesz.   

Abstract

Signature primer pairs designed for use with the polymerase chain reaction have been developed which can determine if a positive result originated from the intended target nucleic acid or from so-called "carry-over" contamination of previously amplified DNA. The 3' ends of each signature primer, SK339/341, SSK110/111, and SSK58/59 contain a viral specific sequence complementary to regions of either HIV-1, HTLV-I and II respectively. The 5' ends of each primer contain a non-human, non-viral (NHNV) signature sequence including restriction endonuclease sites for subsequent cloning. A fourth set of primers, SK338/340, consist solely of these NHNV sequences and are designed to anneal to any product previously amplified by the viral-specific signature primers. These primers were tested against their corresponding positive and negative DNA targets, to determine their specificity and sensitivity. As expected, the viral-specific signature primers detected the retroviral infected samples while no detectable amplification occurred in negative DNA controls. Primers SK338/340 did not amplify any viral positive or negative template DNA's. Samples spiked with amplified material generated from the viral-specific signature primers could be specifically amplified by the NHNV primers SK338/340. Primers SK338/340 were determined to be more sensitive than the viral-specific signature primers, ensuring the detection of extremely low amounts of carryover. This strategy may be useful in developing other retroviral or non-retroviral primers with a built-in signature sequence that can differentiate false positives from true positives in a subsequent confirmatory test.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175947     DOI: 10.1016/0166-0934(94)90016-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  Prevalence of human herpesvirus 8 DNA sequences in several patient populations.

Authors:  C C Marchioli; J L Love; L Z Abbott; Y Q Huang; S C Remick; N Surtento-Reodica; R E Hutchison; D Mildvan; A E Friedman-Kien; B J Poiesz
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

2.  Delayed seroconversion to STLV-1 infection is associated with mutations in the pol and rex genes.

Authors:  Syamalima Dube; Nitin Saksena; Timothy Spicer; Jayne Healey; Patricia Benz; Dipak K Dube; Bernard J Poiesz
Journal:  Virol J       Date:  2013-09-11       Impact factor: 4.099

3.  A new method to prevent carry-over contaminations in two-step PCR NGS library preparations.

Authors:  Volkhard Seitz; Sigrid Schaper; Anja Dröge; Dido Lenze; Michael Hummel; Steffen Hennig
Journal:  Nucleic Acids Res       Date:  2015-07-07       Impact factor: 16.971

4.  Is MMTV associated with human breast cancer? Maybe, but probably not.

Authors:  Raisa Perzova; Lynn Abbott; Patricia Benz; Steve Landas; Seema Khan; Jordan Glaser; Coleen K Cunningham; Bernard Poiesz
Journal:  Virol J       Date:  2017-10-13       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.